NCT01389544View on ClinicalTrials.gov

A Study on the Interaction Between Danoprevir/Ritonavir and Methadone

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

danoprevir

200 mg daily (100 mg q12h) orally, Days 1-10

DRUG

methadone

stable maintenance therapy: 20-120 mg daily single oral morning dose

DRUG

ritonavir

200 mg daily (100 mg q12h) orally, Days 1-10

Trial Locations (2)

66211

Overland Park

92801

Anaheim

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01389544 - A Study on the Interaction Between Danoprevir/Ritonavir and Methadone | Biotech Hunter | Biotech Hunter